NCT03755895View on ClinicalTrials.gov

Contribution of Hypnosis to Anxiety and Pain in Brachytherapy Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

November 2, 2019

Primary Completion Date

May 17, 2022

Study Completion Date

May 25, 2022

Conditions
CancerBrachytherapy
Interventions
OTHER

formal hypnosis

patients will have brachytherapy detachment under Kalinox and formal hypnosis

DRUG

Kalinox

patients will have brachytherapy detachment under Kalinox

Trial Locations (1)

54519

Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Institut de Cancérologie de Lorraine

OTHER

NCT03755895 - Contribution of Hypnosis to Anxiety and Pain in Brachytherapy Patients | Biotech Hunter | Biotech Hunter